CarMax's stock has faced significant pressure, down nearly 50% over the past year. As investors grapple with shifting consumer sentiment and a challenging retail environment, new analysis suggests the market may be undervaluing the company's long-term cash flow potential.
Following a period of strong sales growth, Chili's Grill & Bar is laying the groundwork to potentially grant its general managers a greater ownership stake, a move inspired by industry leaders like Texas Roadhouse and Raising Cane's.
Magellan Aerospace is capturing investor attention with a remarkable 132% surge in earnings per share and significant insider ownership, positioning the aerospace supplier as a standout in the industrial sector.
Barrick Gold Corporation appoints Helen Cai, a current board member with deep capital markets expertise, as its new Chief Financial Officer. The move is seen as reinforcing the mining giant's focus on disciplined financial strategy and project funding in a volatile commodity market.
Missouri's inaugural month of legal sports betting attracted over $540 million in wagers, but aggressive promotions led to a net revenue loss for operators, even as the state collected millions in fees and taxes.
ExxonMobil and Chevron signal that significant investment in Venezuela's vast oil reserves hinges on clearer legal and fiscal stability, despite recent political changes and White House pressure.
HSBC has raised its rating on New Oriental Education & Technology Group (NYSE: EDU) from 'Hold' to 'Buy', following the company's better-than-expected Q2 FY2026 results. The upgrade highlights a robust recovery in core businesses and strategic expansion into new educational initiatives.
Regeneron Pharmaceuticals is positioning its experimental obesity drug, olatorepatide, as a potential game-changer by combining significant weight loss with a dramatic reduction in 'bad' cholesterol. The company believes this dual benefit could carve out a unique niche in the competitive $150 billion market, currently led by Novo Nordisk and Eli Lilly.
Franklin Templeton reported robust first-quarter results, with record long-term inflows of $118.6 billion, driven by strong demand across public and private markets. CEO Jenny Johnson highlighted the firm's strategic positioning in AI, blockchain tokenization, and integrated portfolio solutions as investors seek resilience amid ongoing market volatility.
Chevron capped off a year of strategic execution with record global production and industry-leading free cash flow growth, while outlining ambitious expansion plans from the Caspian to the Caribbean.
The White House has backed away from plans to set minimum prices for domestic critical minerals projects, telling industry leaders that ventures must stand on their own financially. The policy reversal, driven by funding uncertainties and market concerns, marks a significant shift in strategy for bolstering the U.S. supply chain.
Canadian National CEO Tracy Robinson has delivered a stark assessment of the proposed Union Pacific-Norfolk Southern merger, stating the railroads have "a long way to go" to satisfy regulatory concerns. In CN's earnings call, she criticized the application for failing to address competitive harms and warned of impacts on shippers, setting the stage for a contentious review process.
President Donald Trump's selection of former Fed Governor Kevin Warsh to lead the central bank is widely seen as a move to accelerate the rollback of post-crisis financial rules and align regulatory policy more closely with White House objectives, analysts say.
London-based Silphium Asset Management has liquidated its entire $6.2 million position in the Vanguard Long-Term Corporate Bond ETF (VCLT), a move that raises questions about institutional appetite for long-duration credit amid shifting economic forecasts.
Stockholders of CSG Systems International have overwhelmingly approved a slate of key proposals, including governance changes and merger-related actions, during a recent virtual Extraordinary General Meeting. The approvals pave the way for the company's next phase of strategic growth.
Brookfield Business Partners (BBU) reports a strong 2025 defined by strategic capital moves and operational gains across its portfolio. The company is on the cusp of a major corporate reorganization into a single listed entity, aiming to boost liquidity and attract a wider investor base.
Florida-based Seacoast Banking Corporation (SBCF) capped off 2025 with robust loan growth and margin expansion, fueled by its recent acquisition of Villages Bancorporation. Management outlined confident guidance for the coming year, forecasting significant earnings per share growth and improved returns.
Regeneron Pharmaceuticals reported a steady finish to 2025, driven by growth in key drugs Dupixent and EYLEA HD. While navigating competitive pressures on its legacy blockbuster, the biotech giant outlined an ambitious 2026 strategy focused on regulatory milestones and a broad clinical pipeline.
Gentex Corporation delivered a mixed 2025, with Q4 results buoyed by its Vox acquisition and improved core profitability, while tariffs on China exports continued to pressure sales. The automotive tech supplier provided a roadmap focused on advanced mirrors, sensing, and new electrochromic applications like dimmable visors.
Primis Financial (FRST) posted Q4 earnings of $29.5M, buoyed by a one-time gain. Management pegs core quarterly earnings near $8M, citing mortgage growth and deposit mix improvements as key drivers for its 2026 profitability target.
